• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

deal

Grouping of tiles with human figures on them being separated representing layoffs
Biotech

Lisata lays off 72% of staffers, sues Kuva after merger folds

Lisata is laying off 72% of its workforce, including its chief medical officer, after a merger with cancer imaging company Kuva Labs fell apart.
Marissa Russo Aug 4, 2026 9:37am
chronic kidney disease money

Dimerix buys Mission’s kidney disease prospect in $292M deal

Jul 17, 2026 5:00am
handshake deal shake hand arrows ok yes

Olympus pushes deeper into oncology with $270M BioProtect deal

May 26, 2026 3:57pm
research deal two people shaking hands in lab

Astellas, Dyno unearth $15M muscle disorder capsid

Apr 8, 2026 8:00am
Realistic white price tags collection Special offer or shopping discount label

China biotechs ‘reshaping’ US biopharma: Jefferies report

Jul 14, 2025 2:30pm
acquisition merger MA chess game

US biotech finds Relief via reverse merger

Nov 4, 2024 1:05pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings